![](https://webarchive.library.unt.edu/eot2008/20090510222321im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090510222321im_/http://www.cancer.gov/images/spacer.gif)
| Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends. |
Previous Definitions: | follicular large cell lymphoma, follicular lymphoma, follicular mixed cell lymphoma, follicular thyroid cancer, folliculitis | Next Definitions: | fondaparinux, fondaparinux sodium, Food and Drug Administration, foreskin, Form FDA 1572-Statement of Investigator |
|
![](https://webarchive.library.unt.edu/eot2008/20090510222321im_/http://www.cancer.gov/images/spacer.gif) |